Compare Cassava Sciences Inc (FLNA) vs Home Depot Inc (HD) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Home Depot (HD) trades at $341.44, up 1.1% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $370.59 suggesting 8.5% upside. The company reported mixed earnings, beating expectations in Q4 2025 and Q1 2026 but missing in Q3 2025, while maintaining strong profitability with a 33.13% gross margin and 8.41% net margin. Recent institutional activity shows mixed positioning, with some firms increasing and others decreasing holdings.

The outlook is cautiously optimistic given analyst buy ratings (59%) and housing market tailwinds for the Pro business, but risks include weakening big-ticket demand, margin pressure from investments, and sensitivity to rising mortgage rates. The stock recently hit a 52-week low, presenting a potential value opportunity if the company can sustain its professional segment growth amid broader consumer spending caution.